v3.23.1
Consolidated Statements of Convertible Redeemable Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid-in Capital [Member]
Revision of Prior Period, Adjustment [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Class A Redeemable Convertible Preferred Stock [Member]
Convertible Redeemable Preferred Stock [Member]
Class A Redeemable Convertible Preferred Stock [Member]
Convertible Redeemable Preferred Stock [Member]
Revision of Prior Period, Adjustment [Member]
Class B Redeemable Convertible Preferred Stock [Member]
Convertible Redeemable Preferred Stock [Member]
Class B Redeemable Convertible Preferred Stock [Member]
Convertible Redeemable Preferred Stock [Member]
Revision of Prior Period, Adjustment [Member]
Beginning Balance at Dec. 31, 2020 $ (13,218)   $ 1     $ 4,308     $ (1,330)   $ (16,197)   $ 4,687   $ 6,502  
Beginning Balance, Shares at Dec. 31, 2020     9,129,358                   2,042,483   1,459,462  
Beginning Balance, as adjusted, shares at Dec. 31, 2020     39,621,946                   8,864,495   6,334,150  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020   $ (13,218)   $ 4     $ 4,305     $ (1,330)   $ (16,197)        
Beginning Balance, as adjusted at Dec. 31, 2020                         $ 4,687   $ 6,502  
Retroactive application of reverse recapitalization, shares [1]     30,492,588                   6,822,012   4,874,688  
Retroactive application of reverse recapitalization [1]     $ 3     (3)                    
Stock-based compensation 53         53                    
Net income (loss) (65)                   (65)          
Ending Balance at Dec. 31, 2021 (13,230)   $ 4   $ 1 4,358   $ 4,361 (1,330)   (16,262)   $ 4,687   $ 6,502  
Ending Balance, Shares at Dec. 31, 2021     39,621,946   9,129,358               8,864,495 2,042,483 6,334,150 1,459,462
Beginning Balance, as adjusted, shares at Dec. 31, 2021     39,621,946                   8,864,495   6,334,150  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2021   $ (13,230)   $ 4     $ 4,358     $ (1,330)   $ (16,262)        
Beginning Balance, as adjusted at Dec. 31, 2021                         $ 4,687   $ 6,502  
Retroactive application of reverse recapitalization, shares [1]     30,492,588                   6,822,012   4,874,688  
Retroactive application of reverse recapitalization [1]     $ 3     (3)                    
Stock-based compensation 130         130                    
Warrant issuance 713         713                    
Net settlement of liability classified warrants into common stock, shares     202,680                          
Net settlement of liability classified warrants into common stock 1,706         1,706                    
Net settlement of equity classified warrants into common stock, shares     559,051                          
Exercise of stock options 84         84                    
Exercise of stock options, shares     199,147                          
Conversion of redeemable convertible preferred stock to common stock and cancellation of treasury shares, shares     15,198,645                   (8,864,495)   (6,334,150)  
Conversion of redeemable convertible preferred stock to common stock and cancellation of treasury shares 11,189   $ 2     9,857     $ 1,330       $ (4,687)   $ (6,502)  
Reverse capitalization, net of transaction costs, shares     10,864,076                          
Reverse capitalization, net of transaction costs (21,744)   $ 1     (8,439)         (13,306)          
Equity classified warrants issued with PIPE convertible notes 366         366                    
Common stock issued to settle PIPE convertible note issuance costs, shares     48,750                          
Common stock issued to settle PIPE convertible note issuance costs 488         488                    
Net income (loss) (52,726)                   (52,726)          
Ending Balance at Dec. 31, 2022 $ (73,024)   $ 7     $ 9,263         $ (82,294)          
Ending Balance, Shares at Dec. 31, 2022     66,694,295                          
[1] As part of the Business Combination (as disclosed in Note 1), all share information has been retrospectively adjusted using the exchange ratio stipulated by the Merger Agreement.